nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—colon cancer—ovarian cancer	0.248	0.515	CtDrD
Fluorouracil—breast cancer—ovarian cancer	0.233	0.485	CtDrD
Fluorouracil—TYMS—ovarian cancer	0.213	1	CbGaD
Fluorouracil—ABCG2—Topotecan—ovarian cancer	0.0308	0.229	CbGbCtD
Fluorouracil—SLC22A7—Docetaxel—ovarian cancer	0.021	0.156	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—ovarian cancer	0.02	0.149	CbGbCtD
Fluorouracil—ABCG2—Paclitaxel—ovarian cancer	0.0152	0.113	CbGbCtD
Fluorouracil—ABCG2—Carboplatin—ovarian cancer	0.0143	0.107	CbGbCtD
Fluorouracil—ABCG2—Docetaxel—ovarian cancer	0.011	0.082	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—ovarian cancer	0.00821	0.0611	CbGbCtD
Fluorouracil—CYP2C8—Paclitaxel—ovarian cancer	0.00811	0.0604	CbGbCtD
Fluorouracil—CYP2C9—Paclitaxel—ovarian cancer	0.00566	0.0421	CbGbCtD
Fluorouracil—UPP1—myometrium—ovarian cancer	0.00132	0.0288	CbGeAlD
Fluorouracil—UMPS—uterine cervix—ovarian cancer	0.00112	0.0245	CbGeAlD
Fluorouracil—UMPS—decidua—ovarian cancer	0.00106	0.0233	CbGeAlD
Fluorouracil—UPP1—uterine cervix—ovarian cancer	0.00102	0.0224	CbGeAlD
Fluorouracil—UPP1—decidua—ovarian cancer	0.000975	0.0214	CbGeAlD
Fluorouracil—UMPS—uterus—ovarian cancer	0.000931	0.0204	CbGeAlD
Fluorouracil—UPP1—endometrium—ovarian cancer	0.000926	0.0203	CbGeAlD
Fluorouracil—PPAT—myometrium—ovarian cancer	0.000925	0.0203	CbGeAlD
Fluorouracil—UPP1—uterus—ovarian cancer	0.000853	0.0187	CbGeAlD
Fluorouracil—UMPS—female reproductive system—ovarian cancer	0.000837	0.0183	CbGeAlD
Fluorouracil—DPYD—uterine cervix—ovarian cancer	0.000831	0.0182	CbGeAlD
Fluorouracil—DPYD—decidua—ovarian cancer	0.000792	0.0174	CbGeAlD
Fluorouracil—UMPS—bone marrow—ovarian cancer	0.00079	0.0173	CbGeAlD
Fluorouracil—UPP1—female reproductive system—ovarian cancer	0.000767	0.0168	CbGeAlD
Fluorouracil—UMPS—female gonad—ovarian cancer	0.000761	0.0167	CbGeAlD
Fluorouracil—UMPS—vagina—ovarian cancer	0.000757	0.0166	CbGeAlD
Fluorouracil—UPP1—bone marrow—ovarian cancer	0.000724	0.0159	CbGeAlD
Fluorouracil—PPAT—uterine cervix—ovarian cancer	0.00072	0.0158	CbGeAlD
Fluorouracil—UPP1—female gonad—ovarian cancer	0.000698	0.0153	CbGeAlD
Fluorouracil—UPP1—vagina—ovarian cancer	0.000694	0.0152	CbGeAlD
Fluorouracil—DPYD—uterus—ovarian cancer	0.000693	0.0152	CbGeAlD
Fluorouracil—UMPS—testis—ovarian cancer	0.000675	0.0148	CbGeAlD
Fluorouracil—PPAT—endometrium—ovarian cancer	0.000651	0.0143	CbGeAlD
Fluorouracil—UPP1—testis—ovarian cancer	0.000619	0.0136	CbGeAlD
Fluorouracil—TYMP—myometrium—ovarian cancer	0.000619	0.0136	CbGeAlD
Fluorouracil—PPAT—gonad—ovarian cancer	0.000604	0.0132	CbGeAlD
Fluorouracil—DPYD—bone marrow—ovarian cancer	0.000588	0.0129	CbGeAlD
Fluorouracil—DPYD—female gonad—ovarian cancer	0.000567	0.0124	CbGeAlD
Fluorouracil—PPAT—female reproductive system—ovarian cancer	0.000539	0.0118	CbGeAlD
Fluorouracil—PPAT—bone marrow—ovarian cancer	0.000509	0.0112	CbGeAlD
Fluorouracil—DPYD—testis—ovarian cancer	0.000503	0.011	CbGeAlD
Fluorouracil—PPAT—female gonad—ovarian cancer	0.000491	0.0107	CbGeAlD
Fluorouracil—UMPS—lymph node—ovarian cancer	0.000489	0.0107	CbGeAlD
Fluorouracil—PPAT—vagina—ovarian cancer	0.000488	0.0107	CbGeAlD
Fluorouracil—TYMP—uterine cervix—ovarian cancer	0.000482	0.0106	CbGeAlD
Fluorouracil—SLC29A1—myometrium—ovarian cancer	0.000476	0.0104	CbGeAlD
Fluorouracil—TYMP—decidua—ovarian cancer	0.000459	0.0101	CbGeAlD
Fluorouracil—UPP1—lymph node—ovarian cancer	0.000449	0.00983	CbGeAlD
Fluorouracil—TYMP—endometrium—ovarian cancer	0.000436	0.00954	CbGeAlD
Fluorouracil—PPAT—testis—ovarian cancer	0.000435	0.00953	CbGeAlD
Fluorouracil—TYMS—uterine cervix—ovarian cancer	0.000413	0.00905	CbGeAlD
Fluorouracil—ABCC5—uterine cervix—ovarian cancer	0.000404	0.00884	CbGeAlD
Fluorouracil—TYMP—uterus—ovarian cancer	0.000401	0.0088	CbGeAlD
Fluorouracil—ABCC5—decidua—ovarian cancer	0.000385	0.00843	CbGeAlD
Fluorouracil—TYMS—endometrium—ovarian cancer	0.000374	0.00819	CbGeAlD
Fluorouracil—SLC29A1—uterine cervix—ovarian cancer	0.000371	0.00812	CbGeAlD
Fluorouracil—DPYD—lymph node—ovarian cancer	0.000364	0.00798	CbGeAlD
Fluorouracil—TYMP—female reproductive system—ovarian cancer	0.000361	0.00791	CbGeAlD
Fluorouracil—SLC29A1—decidua—ovarian cancer	0.000353	0.00774	CbGeAlD
Fluorouracil—TYMS—gonad—ovarian cancer	0.000347	0.0076	CbGeAlD
Fluorouracil—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.000342	0.167	CbGdCrCtD
Fluorouracil—TYMP—bone marrow—ovarian cancer	0.000341	0.00746	CbGeAlD
Fluorouracil—MTHFR—female reproductive system—ovarian cancer	0.000339	0.00743	CbGeAlD
Fluorouracil—SLC29A1—endometrium—ovarian cancer	0.000335	0.00734	CbGeAlD
Fluorouracil—TYMP—female gonad—ovarian cancer	0.000328	0.00719	CbGeAlD
Fluorouracil—TYMP—vagina—ovarian cancer	0.000326	0.00715	CbGeAlD
Fluorouracil—ABCC3—decidua—ovarian cancer	0.000323	0.00708	CbGeAlD
Fluorouracil—PPAT—lymph node—ovarian cancer	0.000315	0.00691	CbGeAlD
Fluorouracil—SLC29A1—gonad—ovarian cancer	0.000311	0.00681	CbGeAlD
Fluorouracil—TYMS—female reproductive system—ovarian cancer	0.00031	0.00678	CbGeAlD
Fluorouracil—SLC29A1—uterus—ovarian cancer	0.000309	0.00677	CbGeAlD
Fluorouracil—MTHFR—female gonad—ovarian cancer	0.000309	0.00676	CbGeAlD
Fluorouracil—TYMS—bone marrow—ovarian cancer	0.000292	0.0064	CbGeAlD
Fluorouracil—TYMP—testis—ovarian cancer	0.000291	0.00638	CbGeAlD
Fluorouracil—SLC22A7—testis—ovarian cancer	0.00029	0.00636	CbGeAlD
Fluorouracil—ABCC5—bone marrow—ovarian cancer	0.000286	0.00626	CbGeAlD
Fluorouracil—TYMS—female gonad—ovarian cancer	0.000282	0.00617	CbGeAlD
Fluorouracil—TYMS—vagina—ovarian cancer	0.00028	0.00614	CbGeAlD
Fluorouracil—SLC29A1—female reproductive system—ovarian cancer	0.000278	0.00608	CbGeAlD
Fluorouracil—ABCC5—female gonad—ovarian cancer	0.000275	0.00603	CbGeAlD
Fluorouracil—MTHFR—testis—ovarian cancer	0.000274	0.006	CbGeAlD
Fluorouracil—ABCC5—vagina—ovarian cancer	0.000274	0.00599	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—ovarian cancer	0.000262	0.00574	CbGeAlD
Fluorouracil—ABCC3—female reproductive system—ovarian cancer	0.000254	0.00556	CbGeAlD
Fluorouracil—ABCG2—myometrium—ovarian cancer	0.000254	0.00556	CbGeAlD
Fluorouracil—SLC29A1—female gonad—ovarian cancer	0.000253	0.00554	CbGeAlD
Fluorouracil—SLC29A1—vagina—ovarian cancer	0.000251	0.0055	CbGeAlD
Fluorouracil—TYMS—testis—ovarian cancer	0.00025	0.00547	CbGeAlD
Fluorouracil—CYP2A6—vagina—ovarian cancer	0.000245	0.00537	CbGeAlD
Fluorouracil—ABCC5—testis—ovarian cancer	0.000244	0.00535	CbGeAlD
Fluorouracil—ABCC4—uterus—ovarian cancer	0.000233	0.00511	CbGeAlD
Fluorouracil—ABCC3—female gonad—ovarian cancer	0.000231	0.00506	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—ovarian cancer	0.000228	0.112	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—ovarian cancer	0.000228	0.112	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—ovarian cancer	0.000228	0.112	CbGdCrCtD
Fluorouracil—SLC29A1—testis—ovarian cancer	0.000224	0.00491	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—ovarian cancer	0.000211	0.103	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—ovarian cancer	0.000211	0.103	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—ovarian cancer	0.000211	0.103	CbGdCrCtD
Fluorouracil—TYMP—lymph node—ovarian cancer	0.000211	0.00463	CbGeAlD
Fluorouracil—ABCC4—female reproductive system—ovarian cancer	0.00021	0.00459	CbGeAlD
Fluorouracil—ABCC3—testis—ovarian cancer	0.000205	0.00449	CbGeAlD
Fluorouracil—MTHFR—lymph node—ovarian cancer	0.000199	0.00435	CbGeAlD
Fluorouracil—ABCC4—bone marrow—ovarian cancer	0.000198	0.00434	CbGeAlD
Fluorouracil—ABCG2—uterine cervix—ovarian cancer	0.000198	0.00433	CbGeAlD
Fluorouracil—ABCC4—female gonad—ovarian cancer	0.000191	0.00418	CbGeAlD
Fluorouracil—ABCG2—decidua—ovarian cancer	0.000188	0.00412	CbGeAlD
Fluorouracil—CYP2C8—endometrium—ovarian cancer	0.000184	0.00402	CbGeAlD
Fluorouracil—TYMS—lymph node—ovarian cancer	0.000181	0.00397	CbGeAlD
Fluorouracil—ABCG2—endometrium—ovarian cancer	0.000179	0.00391	CbGeAlD
Fluorouracil—ABCC5—lymph node—ovarian cancer	0.000177	0.00388	CbGeAlD
Fluorouracil—ALB—testis—ovarian cancer	0.000175	0.00383	CbGeAlD
Fluorouracil—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.000171	0.0835	CbGdCrCtD
Fluorouracil—ABCC4—testis—ovarian cancer	0.000169	0.00371	CbGeAlD
Fluorouracil—ABCG2—uterus—ovarian cancer	0.000165	0.00361	CbGeAlD
Fluorouracil—SLC29A1—lymph node—ovarian cancer	0.000162	0.00356	CbGeAlD
Fluorouracil—CYP2C8—female reproductive system—ovarian cancer	0.000152	0.00333	CbGeAlD
Fluorouracil—ABCC3—lymph node—ovarian cancer	0.000149	0.00325	CbGeAlD
Fluorouracil—ABCG2—bone marrow—ovarian cancer	0.00014	0.00306	CbGeAlD
Fluorouracil—CYP2C8—vagina—ovarian cancer	0.000138	0.00302	CbGeAlD
Fluorouracil—CYP2C9—female reproductive system—ovarian cancer	0.000135	0.00296	CbGeAlD
Fluorouracil—ABCG2—female gonad—ovarian cancer	0.000135	0.00295	CbGeAlD
Fluorouracil—ABCG2—vagina—ovarian cancer	0.000134	0.00293	CbGeAlD
Fluorouracil—ALB—lymph node—ovarian cancer	0.000127	0.00278	CbGeAlD
Fluorouracil—CYP2C8—testis—ovarian cancer	0.000123	0.00269	CbGeAlD
Fluorouracil—ABCC4—lymph node—ovarian cancer	0.000123	0.00269	CbGeAlD
Fluorouracil—ABCG2—testis—ovarian cancer	0.000119	0.00262	CbGeAlD
Fluorouracil—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000117	0.0574	CbGdCrCtD
Fluorouracil—TYMS—Vinblastine—Vinorelbine—ovarian cancer	9.43e-05	0.0462	CbGdCrCtD
Fluorouracil—ABCG2—lymph node—ovarian cancer	8.66e-05	0.0019	CbGeAlD
Fluorouracil—Pruritus—Topotecan—ovarian cancer	7.02e-05	0.000899	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—ovarian cancer	7e-05	0.000896	CcSEcCtD
Fluorouracil—Erythema—Paclitaxel—ovarian cancer	7e-05	0.000896	CcSEcCtD
Fluorouracil—Feeling abnormal—Vinorelbine—ovarian cancer	6.99e-05	0.000896	CcSEcCtD
Fluorouracil—Dermatitis bullous—Epirubicin—ovarian cancer	6.95e-05	0.00089	CcSEcCtD
Fluorouracil—Pruritus—Melphalan—ovarian cancer	6.87e-05	0.00088	CcSEcCtD
Fluorouracil—Haemoglobin—Docetaxel—ovarian cancer	6.85e-05	0.000877	CcSEcCtD
Fluorouracil—Rhinitis—Docetaxel—ovarian cancer	6.83e-05	0.000874	CcSEcCtD
Fluorouracil—Haemorrhage—Docetaxel—ovarian cancer	6.81e-05	0.000872	CcSEcCtD
Fluorouracil—Cardiac failure—Epirubicin—ovarian cancer	6.8e-05	0.000871	CcSEcCtD
Fluorouracil—Diarrhoea—Topotecan—ovarian cancer	6.79e-05	0.000869	CcSEcCtD
Fluorouracil—Hypoaesthesia—Docetaxel—ovarian cancer	6.78e-05	0.000868	CcSEcCtD
Fluorouracil—Lethargy—Epirubicin—ovarian cancer	6.78e-05	0.000868	CcSEcCtD
Fluorouracil—Pharyngitis—Docetaxel—ovarian cancer	6.76e-05	0.000866	CcSEcCtD
Fluorouracil—Urticaria—Vinorelbine—ovarian cancer	6.74e-05	0.000864	CcSEcCtD
Fluorouracil—Body temperature increased—Vinorelbine—ovarian cancer	6.71e-05	0.000859	CcSEcCtD
Fluorouracil—Diarrhoea—Melphalan—ovarian cancer	6.65e-05	0.000851	CcSEcCtD
Fluorouracil—Osteoarthritis—Epirubicin—ovarian cancer	6.64e-05	0.00085	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	6.64e-05	0.00085	CcSEcCtD
Fluorouracil—Nausea—Chlorambucil—ovarian cancer	6.62e-05	0.000848	CcSEcCtD
Fluorouracil—Vision blurred—Paclitaxel—ovarian cancer	6.59e-05	0.000844	CcSEcCtD
Fluorouracil—Dizziness—Topotecan—ovarian cancer	6.56e-05	0.00084	CcSEcCtD
Fluorouracil—Anaemia—Paclitaxel—ovarian cancer	6.47e-05	0.000828	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—ovarian cancer	6.43e-05	0.000823	CcSEcCtD
Fluorouracil—Cardiac arrest—Epirubicin—ovarian cancer	6.31e-05	0.000809	CcSEcCtD
Fluorouracil—Vomiting—Topotecan—ovarian cancer	6.31e-05	0.000808	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—ovarian cancer	6.3e-05	0.000806	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—ovarian cancer	6.27e-05	0.000803	CcSEcCtD
Fluorouracil—Leukopenia—Paclitaxel—ovarian cancer	6.26e-05	0.000802	CcSEcCtD
Fluorouracil—Rash—Topotecan—ovarian cancer	6.26e-05	0.000801	CcSEcCtD
Fluorouracil—Hypersensitivity—Vinorelbine—ovarian cancer	6.25e-05	0.000801	CcSEcCtD
Fluorouracil—Dermatitis—Topotecan—ovarian cancer	6.25e-05	0.0008	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—ovarian cancer	6.24e-05	0.0008	CcSEcCtD
Fluorouracil—Headache—Topotecan—ovarian cancer	6.22e-05	0.000796	CcSEcCtD
Fluorouracil—Vomiting—Melphalan—ovarian cancer	6.18e-05	0.000791	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—ovarian cancer	6.14e-05	0.000787	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	6.14e-05	0.000787	CcSEcCtD
Fluorouracil—Rash—Melphalan—ovarian cancer	6.13e-05	0.000784	CcSEcCtD
Fluorouracil—Dermatitis—Melphalan—ovarian cancer	6.12e-05	0.000784	CcSEcCtD
Fluorouracil—Dry skin—Epirubicin—ovarian cancer	6.09e-05	0.00078	CcSEcCtD
Fluorouracil—Arrhythmia—Docetaxel—ovarian cancer	6.08e-05	0.000779	CcSEcCtD
Fluorouracil—Convulsion—Paclitaxel—ovarian cancer	6.06e-05	0.000776	CcSEcCtD
Fluorouracil—Alopecia—Docetaxel—ovarian cancer	6.02e-05	0.000771	CcSEcCtD
Fluorouracil—Pruritus—Vinorelbine—ovarian cancer	6.01e-05	0.000769	CcSEcCtD
Fluorouracil—Myalgia—Paclitaxel—ovarian cancer	5.96e-05	0.000763	CcSEcCtD
Fluorouracil—Chest pain—Paclitaxel—ovarian cancer	5.96e-05	0.000763	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—ovarian cancer	5.94e-05	0.00076	CcSEcCtD
Fluorouracil—Erythema—Docetaxel—ovarian cancer	5.93e-05	0.000759	CcSEcCtD
Fluorouracil—Nausea—Topotecan—ovarian cancer	5.89e-05	0.000755	CcSEcCtD
Fluorouracil—Discomfort—Paclitaxel—ovarian cancer	5.88e-05	0.000754	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—ovarian cancer	5.86e-05	0.00075	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—ovarian cancer	5.84e-05	0.000748	CcSEcCtD
Fluorouracil—Diarrhoea—Vinorelbine—ovarian cancer	5.81e-05	0.000744	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—ovarian cancer	5.78e-05	0.00074	CcSEcCtD
Fluorouracil—Nausea—Melphalan—ovarian cancer	5.77e-05	0.000739	CcSEcCtD
Fluorouracil—Confusional state—Paclitaxel—ovarian cancer	5.76e-05	0.000737	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—ovarian cancer	5.74e-05	0.000735	CcSEcCtD
Fluorouracil—Anaphylactic shock—Paclitaxel—ovarian cancer	5.71e-05	0.000731	CcSEcCtD
Fluorouracil—Oedema—Paclitaxel—ovarian cancer	5.71e-05	0.000731	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—ovarian cancer	5.68e-05	0.000728	CcSEcCtD
Fluorouracil—Infection—Paclitaxel—ovarian cancer	5.67e-05	0.000726	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—ovarian cancer	5.63e-05	0.000721	CcSEcCtD
Fluorouracil—Dizziness—Vinorelbine—ovarian cancer	5.61e-05	0.000719	CcSEcCtD
Fluorouracil—Nervous system disorder—Paclitaxel—ovarian cancer	5.6e-05	0.000717	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—ovarian cancer	5.59e-05	0.000716	CcSEcCtD
Fluorouracil—Thrombocytopenia—Paclitaxel—ovarian cancer	5.59e-05	0.000716	CcSEcCtD
Fluorouracil—Tachycardia—Paclitaxel—ovarian cancer	5.57e-05	0.000714	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—ovarian cancer	5.49e-05	0.000704	CcSEcCtD
Fluorouracil—Anaemia—Docetaxel—ovarian cancer	5.48e-05	0.000702	CcSEcCtD
Fluorouracil—Pancytopenia—Epirubicin—ovarian cancer	5.45e-05	0.000698	CcSEcCtD
Fluorouracil—Anorexia—Paclitaxel—ovarian cancer	5.44e-05	0.000697	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—ovarian cancer	5.42e-05	0.000694	CcSEcCtD
Fluorouracil—Vomiting—Vinorelbine—ovarian cancer	5.4e-05	0.000691	CcSEcCtD
Fluorouracil—Rash—Vinorelbine—ovarian cancer	5.35e-05	0.000685	CcSEcCtD
Fluorouracil—Dermatitis—Vinorelbine—ovarian cancer	5.35e-05	0.000685	CcSEcCtD
Fluorouracil—Hypotension—Paclitaxel—ovarian cancer	5.33e-05	0.000683	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—ovarian cancer	5.33e-05	0.000683	CcSEcCtD
Fluorouracil—Headache—Vinorelbine—ovarian cancer	5.32e-05	0.000681	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—ovarian cancer	5.31e-05	0.00068	CcSEcCtD
Fluorouracil—Leukopenia—Docetaxel—ovarian cancer	5.31e-05	0.00068	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—ovarian cancer	5.26e-05	0.000673	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—ovarian cancer	5.24e-05	0.000671	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	5.2e-05	0.000666	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—ovarian cancer	5.17e-05	0.000663	CcSEcCtD
Fluorouracil—Insomnia—Paclitaxel—ovarian cancer	5.16e-05	0.000661	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—ovarian cancer	5.15e-05	0.000659	CcSEcCtD
Fluorouracil—Convulsion—Docetaxel—ovarian cancer	5.14e-05	0.000658	CcSEcCtD
Fluorouracil—Paraesthesia—Paclitaxel—ovarian cancer	5.13e-05	0.000657	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—ovarian cancer	5.12e-05	0.000655	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—ovarian cancer	5.12e-05	0.000655	CcSEcCtD
Fluorouracil—Dyspnoea—Paclitaxel—ovarian cancer	5.09e-05	0.000652	CcSEcCtD
Fluorouracil—Somnolence—Paclitaxel—ovarian cancer	5.08e-05	0.00065	CcSEcCtD
Fluorouracil—Chest pain—Docetaxel—ovarian cancer	5.05e-05	0.000646	CcSEcCtD
Fluorouracil—Myalgia—Docetaxel—ovarian cancer	5.05e-05	0.000646	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—ovarian cancer	5.04e-05	0.000646	CcSEcCtD
Fluorouracil—Nausea—Vinorelbine—ovarian cancer	5.04e-05	0.000646	CcSEcCtD
Fluorouracil—Dyspepsia—Paclitaxel—ovarian cancer	5.03e-05	0.000644	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—ovarian cancer	5.02e-05	0.000642	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—ovarian cancer	4.99e-05	0.000639	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—ovarian cancer	4.97e-05	0.000637	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—ovarian cancer	4.97e-05	0.000637	CcSEcCtD
Fluorouracil—Decreased appetite—Paclitaxel—ovarian cancer	4.96e-05	0.000636	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—ovarian cancer	4.94e-05	0.000632	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	4.93e-05	0.000631	CcSEcCtD
Fluorouracil—Pain—Paclitaxel—ovarian cancer	4.88e-05	0.000625	CcSEcCtD
Fluorouracil—Confusional state—Docetaxel—ovarian cancer	4.88e-05	0.000625	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—ovarian cancer	4.85e-05	0.000621	CcSEcCtD
Fluorouracil—Anaphylactic shock—Docetaxel—ovarian cancer	4.84e-05	0.00062	CcSEcCtD
Fluorouracil—Oedema—Docetaxel—ovarian cancer	4.84e-05	0.00062	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—ovarian cancer	4.83e-05	0.000618	CcSEcCtD
Fluorouracil—Infection—Docetaxel—ovarian cancer	4.81e-05	0.000616	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—ovarian cancer	4.8e-05	0.000615	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—ovarian cancer	4.78e-05	0.000612	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—ovarian cancer	4.76e-05	0.00061	CcSEcCtD
Fluorouracil—Nervous system disorder—Docetaxel—ovarian cancer	4.75e-05	0.000608	CcSEcCtD
Fluorouracil—Thrombocytopenia—Docetaxel—ovarian cancer	4.74e-05	0.000607	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—ovarian cancer	4.74e-05	0.000606	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—ovarian cancer	4.74e-05	0.000606	CcSEcCtD
Fluorouracil—Tachycardia—Docetaxel—ovarian cancer	4.72e-05	0.000605	CcSEcCtD
Fluorouracil—Feeling abnormal—Paclitaxel—ovarian cancer	4.7e-05	0.000602	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—ovarian cancer	4.64e-05	0.000594	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—ovarian cancer	4.62e-05	0.000591	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—ovarian cancer	4.62e-05	0.000591	CcSEcCtD
Fluorouracil—Anorexia—Docetaxel—ovarian cancer	4.61e-05	0.000591	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—ovarian cancer	4.61e-05	0.00059	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—ovarian cancer	4.6e-05	0.000589	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—ovarian cancer	4.6e-05	0.000589	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—ovarian cancer	4.59e-05	0.000588	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—ovarian cancer	4.57e-05	0.000585	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—ovarian cancer	4.56e-05	0.000584	CcSEcCtD
Fluorouracil—Urticaria—Paclitaxel—ovarian cancer	4.54e-05	0.000581	CcSEcCtD
Fluorouracil—Hypotension—Docetaxel—ovarian cancer	4.52e-05	0.000579	CcSEcCtD
Fluorouracil—Body temperature increased—Paclitaxel—ovarian cancer	4.51e-05	0.000578	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—ovarian cancer	4.47e-05	0.000572	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—ovarian cancer	4.44e-05	0.000569	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—ovarian cancer	4.42e-05	0.000566	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	4.41e-05	0.000565	CcSEcCtD
Fluorouracil—Insomnia—Docetaxel—ovarian cancer	4.38e-05	0.000561	CcSEcCtD
Fluorouracil—Paraesthesia—Docetaxel—ovarian cancer	4.35e-05	0.000556	CcSEcCtD
Fluorouracil—Dyspnoea—Docetaxel—ovarian cancer	4.31e-05	0.000552	CcSEcCtD
Fluorouracil—Somnolence—Docetaxel—ovarian cancer	4.3e-05	0.000551	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—ovarian cancer	4.27e-05	0.000547	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—ovarian cancer	4.26e-05	0.000546	CcSEcCtD
Fluorouracil—Dyspepsia—Docetaxel—ovarian cancer	4.26e-05	0.000546	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—ovarian cancer	4.25e-05	0.000544	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—ovarian cancer	4.23e-05	0.000542	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—ovarian cancer	4.22e-05	0.00054	CcSEcCtD
Fluorouracil—Decreased appetite—Docetaxel—ovarian cancer	4.21e-05	0.000539	CcSEcCtD
Fluorouracil—Hypersensitivity—Paclitaxel—ovarian cancer	4.21e-05	0.000539	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Docetaxel—ovarian cancer	4.18e-05	0.000535	CcSEcCtD
Fluorouracil—Pain—Docetaxel—ovarian cancer	4.14e-05	0.00053	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—ovarian cancer	4.1e-05	0.000526	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—ovarian cancer	4.06e-05	0.00052	CcSEcCtD
Fluorouracil—Pruritus—Paclitaxel—ovarian cancer	4.04e-05	0.000517	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—ovarian cancer	4e-05	0.000512	CcSEcCtD
Fluorouracil—Feeling abnormal—Docetaxel—ovarian cancer	3.99e-05	0.000511	CcSEcCtD
Fluorouracil—Diarrhoea—Paclitaxel—ovarian cancer	3.91e-05	0.0005	CcSEcCtD
Fluorouracil—Body temperature increased—Docetaxel—ovarian cancer	3.83e-05	0.00049	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—ovarian cancer	3.8e-05	0.000486	CcSEcCtD
Fluorouracil—Dizziness—Paclitaxel—ovarian cancer	3.78e-05	0.000483	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—ovarian cancer	3.77e-05	0.000483	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—ovarian cancer	3.76e-05	0.000481	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—ovarian cancer	3.7e-05	0.000474	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—ovarian cancer	3.7e-05	0.000473	CcSEcCtD
Fluorouracil—Vomiting—Paclitaxel—ovarian cancer	3.63e-05	0.000465	CcSEcCtD
Fluorouracil—Rash—Paclitaxel—ovarian cancer	3.6e-05	0.000461	CcSEcCtD
Fluorouracil—Dermatitis—Paclitaxel—ovarian cancer	3.6e-05	0.000461	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—ovarian cancer	3.58e-05	0.000458	CcSEcCtD
Fluorouracil—Headache—Paclitaxel—ovarian cancer	3.58e-05	0.000458	CcSEcCtD
Fluorouracil—Hypersensitivity—Docetaxel—ovarian cancer	3.57e-05	0.000457	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—ovarian cancer	3.49e-05	0.000447	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—ovarian cancer	3.47e-05	0.000444	CcSEcCtD
Fluorouracil—Pruritus—Docetaxel—ovarian cancer	3.42e-05	0.000438	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—ovarian cancer	3.42e-05	0.000438	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—ovarian cancer	3.4e-05	0.000436	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—ovarian cancer	3.4e-05	0.000436	CcSEcCtD
Fluorouracil—Nausea—Paclitaxel—ovarian cancer	3.39e-05	0.000434	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—ovarian cancer	3.36e-05	0.000431	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—ovarian cancer	3.31e-05	0.000424	CcSEcCtD
Fluorouracil—Diarrhoea—Docetaxel—ovarian cancer	3.31e-05	0.000424	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—ovarian cancer	3.29e-05	0.000421	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—ovarian cancer	3.26e-05	0.000418	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—ovarian cancer	3.26e-05	0.000418	CcSEcCtD
Fluorouracil—Infection—Epirubicin—ovarian cancer	3.24e-05	0.000415	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—ovarian cancer	3.21e-05	0.000411	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—ovarian cancer	3.2e-05	0.00041	CcSEcCtD
Fluorouracil—Dizziness—Docetaxel—ovarian cancer	3.2e-05	0.00041	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—ovarian cancer	3.2e-05	0.000409	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—ovarian cancer	3.19e-05	0.000408	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—ovarian cancer	3.15e-05	0.000403	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—ovarian cancer	3.15e-05	0.000403	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—ovarian cancer	3.11e-05	0.000399	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—ovarian cancer	3.11e-05	0.000398	CcSEcCtD
Fluorouracil—Vomiting—Docetaxel—ovarian cancer	3.08e-05	0.000394	CcSEcCtD
Fluorouracil—Rash—Docetaxel—ovarian cancer	3.05e-05	0.000391	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—ovarian cancer	3.05e-05	0.000391	CcSEcCtD
Fluorouracil—Dermatitis—Docetaxel—ovarian cancer	3.05e-05	0.00039	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—ovarian cancer	3.05e-05	0.00039	CcSEcCtD
Fluorouracil—Headache—Docetaxel—ovarian cancer	3.03e-05	0.000388	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—ovarian cancer	3.02e-05	0.000387	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—ovarian cancer	3.02e-05	0.000387	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—ovarian cancer	3e-05	0.000384	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	2.97e-05	0.000381	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—ovarian cancer	2.96e-05	0.000379	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—ovarian cancer	2.96e-05	0.000379	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—ovarian cancer	2.95e-05	0.000378	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—ovarian cancer	2.95e-05	0.000377	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—ovarian cancer	2.93e-05	0.000375	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—ovarian cancer	2.91e-05	0.000373	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—ovarian cancer	2.9e-05	0.000372	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—ovarian cancer	2.88e-05	0.000369	CcSEcCtD
Fluorouracil—Nausea—Docetaxel—ovarian cancer	2.87e-05	0.000368	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—ovarian cancer	2.87e-05	0.000368	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—ovarian cancer	2.84e-05	0.000363	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—ovarian cancer	2.82e-05	0.000361	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—ovarian cancer	2.82e-05	0.000361	CcSEcCtD
Fluorouracil—Pain—Epirubicin—ovarian cancer	2.79e-05	0.000357	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	2.75e-05	0.000352	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—ovarian cancer	2.73e-05	0.00035	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—ovarian cancer	2.71e-05	0.000347	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—ovarian cancer	2.69e-05	0.000345	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—ovarian cancer	2.69e-05	0.000344	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—ovarian cancer	2.68e-05	0.000344	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—ovarian cancer	2.66e-05	0.00034	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—ovarian cancer	2.63e-05	0.000336	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	2.61e-05	0.000334	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—ovarian cancer	2.59e-05	0.000332	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—ovarian cancer	2.58e-05	0.000331	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—ovarian cancer	2.58e-05	0.00033	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—ovarian cancer	2.49e-05	0.000319	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—ovarian cancer	2.4e-05	0.000308	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—ovarian cancer	2.4e-05	0.000307	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—ovarian cancer	2.39e-05	0.000306	CcSEcCtD
Fluorouracil—Pruritus—Epirubicin—ovarian cancer	2.31e-05	0.000296	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—ovarian cancer	2.23e-05	0.000286	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—ovarian cancer	2.23e-05	0.000285	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—ovarian cancer	2.16e-05	0.000276	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—ovarian cancer	2.14e-05	0.000274	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—ovarian cancer	2.08e-05	0.000266	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—ovarian cancer	2.07e-05	0.000265	CcSEcCtD
Fluorouracil—Rash—Epirubicin—ovarian cancer	2.06e-05	0.000264	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—ovarian cancer	2.06e-05	0.000263	CcSEcCtD
Fluorouracil—Headache—Epirubicin—ovarian cancer	2.04e-05	0.000262	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—ovarian cancer	2e-05	0.000256	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—ovarian cancer	1.94e-05	0.000248	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—ovarian cancer	1.92e-05	0.000246	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—ovarian cancer	1.9e-05	0.000244	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—ovarian cancer	1.9e-05	0.000244	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—ovarian cancer	1.89e-05	0.000242	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—ovarian cancer	1.79e-05	0.00023	CcSEcCtD
Fluorouracil—TYMS—Metabolism—ABCB1—ovarian cancer	7.63e-06	0.000165	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYTB—ovarian cancer	7.54e-06	0.000163	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.52e-06	0.000163	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYTB—ovarian cancer	7.49e-06	0.000162	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CD—ovarian cancer	7.44e-06	0.000161	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IL2—ovarian cancer	7.43e-06	0.000161	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—APC—ovarian cancer	7.37e-06	0.00016	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.37e-06	0.00016	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.32e-06	0.000159	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.26e-06	0.000157	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MAPK3—ovarian cancer	7.24e-06	0.000157	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SOD1—ovarian cancer	7.17e-06	0.000155	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PPP2R1A—ovarian cancer	7.14e-06	0.000155	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—YAP1—ovarian cancer	7.12e-06	0.000154	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTEN—ovarian cancer	7.12e-06	0.000154	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	7.1e-06	0.000154	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CG—ovarian cancer	7.09e-06	0.000154	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PIK3CA—ovarian cancer	7.05e-06	0.000153	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PIK3CA—ovarian cancer	7.05e-06	0.000153	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—ovarian cancer	7.04e-06	0.000153	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.9e-06	0.00015	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MAPK1—ovarian cancer	6.89e-06	0.000149	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPP2R1A—ovarian cancer	6.8e-06	0.000147	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CAV1—ovarian cancer	6.78e-06	0.000147	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.77e-06	0.000147	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BRIP1—ovarian cancer	6.59e-06	0.000143	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPP1CC—ovarian cancer	6.59e-06	0.000143	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.58e-06	0.000143	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB2—ovarian cancer	6.57e-06	0.000142	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BRIP1—ovarian cancer	6.55e-06	0.000142	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPP1CC—ovarian cancer	6.55e-06	0.000142	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	6.52e-06	0.000141	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MTOR—ovarian cancer	6.49e-06	0.000141	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CB—ovarian cancer	6.49e-06	0.000141	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CD—ovarian cancer	6.48e-06	0.00014	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—YAP1—ovarian cancer	6.47e-06	0.00014	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ABCB1—ovarian cancer	6.31e-06	0.000137	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—ovarian cancer	6.31e-06	0.000137	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—ovarian cancer	6.23e-06	0.000135	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CD—ovarian cancer	6.23e-06	0.000135	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TYMS—ovarian cancer	6.2e-06	0.000134	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CG—ovarian cancer	6.17e-06	0.000134	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYTB—ovarian cancer	6.13e-06	0.000133	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN1B—ovarian cancer	6.09e-06	0.000132	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CAV1—ovarian cancer	6.04e-06	0.000131	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6e-06	0.00013	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—MAPK3—ovarian cancer	5.97e-06	0.000129	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—FASN—ovarian cancer	5.8e-06	0.000126	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—ovarian cancer	5.78e-06	0.000125	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—ovarian cancer	5.76e-06	0.000125	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—ovarian cancer	5.76e-06	0.000125	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—ovarian cancer	5.75e-06	0.000125	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.74e-06	0.000124	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB2—ovarian cancer	5.72e-06	0.000124	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC5A5—ovarian cancer	5.71e-06	0.000124	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—MAPK1—ovarian cancer	5.68e-06	0.000123	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTOR—ovarian cancer	5.65e-06	0.000122	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CB—ovarian cancer	5.65e-06	0.000122	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.63e-06	0.000122	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTEN—ovarian cancer	5.61e-06	0.000122	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	5.54e-06	0.00012	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC2A1—ovarian cancer	5.51e-06	0.000119	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CG—ovarian cancer	5.5e-06	0.000119	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CB—ovarian cancer	5.43e-06	0.000118	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CD—ovarian cancer	5.43e-06	0.000118	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—ovarian cancer	5.37e-06	0.000116	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BRIP1—ovarian cancer	5.36e-06	0.000116	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	5.36e-06	0.000116	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1B—ovarian cancer	5.3e-06	0.000115	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP1B1—ovarian cancer	5.29e-06	0.000115	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—FASN—ovarian cancer	5.27e-06	0.000114	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—CAV1—ovarian cancer	5.24e-06	0.000114	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYTB—ovarian cancer	5.24e-06	0.000114	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	5.24e-06	0.000114	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC5A5—ovarian cancer	5.19e-06	0.000112	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.12e-06	0.000111	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—ovarian cancer	5.02e-06	0.000109	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—ovarian cancer	5.01e-06	0.000109	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC2A1—ovarian cancer	5.01e-06	0.000109	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—ovarian cancer	5.01e-06	0.000109	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—ovarian cancer	5e-06	0.000108	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CAV1—ovarian cancer	5e-06	0.000108	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	4.99e-06	0.000108	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—ovarian cancer	4.93e-06	0.000107	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTEN—ovarian cancer	4.88e-06	0.000106	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CD—ovarian cancer	4.83e-06	0.000105	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1B1—ovarian cancer	4.8e-06	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.8e-06	0.000104	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAPK3—ovarian cancer	4.79e-06	0.000104	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CG—ovarian cancer	4.78e-06	0.000104	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.77e-06	0.000103	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.77e-06	0.000103	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—ovarian cancer	4.77e-06	0.000103	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CB—ovarian cancer	4.73e-06	0.000103	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTEN—ovarian cancer	4.7e-06	0.000102	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPP2R1A—ovarian cancer	4.69e-06	0.000102	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—ovarian cancer	4.66e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BRIP1—ovarian cancer	4.58e-06	9.93e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPP1CC—ovarian cancer	4.58e-06	9.93e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—ovarian cancer	4.56e-06	9.89e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAPK1—ovarian cancer	4.56e-06	9.88e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—ovarian cancer	4.56e-06	9.88e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CG—ovarian cancer	4.55e-06	9.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—YAP1—ovarian cancer	4.42e-06	9.58e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—YAP1—ovarian cancer	4.39e-06	9.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.37e-06	9.48e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—ovarian cancer	4.37e-06	9.46e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—ovarian cancer	4.35e-06	9.44e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ABCB1—ovarian cancer	4.35e-06	9.43e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.35e-06	9.42e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	4.33e-06	9.38e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—ovarian cancer	4.31e-06	9.33e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TYMS—ovarian cancer	4.28e-06	9.27e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	4.26e-06	9.23e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CB—ovarian cancer	4.21e-06	9.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CD—ovarian cancer	4.2e-06	9.1e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK3—ovarian cancer	4.17e-06	9.04e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—ovarian cancer	4.1e-06	8.89e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—ovarian cancer	4.09e-06	8.86e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—ovarian cancer	4.06e-06	8.79e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—ovarian cancer	4.03e-06	8.73e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CD—ovarian cancer	4e-06	8.67e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK1—ovarian cancer	3.97e-06	8.6e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—ovarian cancer	3.97e-06	8.6e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—ovarian cancer	3.96e-06	8.57e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—ovarian cancer	3.96e-06	8.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.91e-06	8.47e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TYMS—ovarian cancer	3.88e-06	8.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.84e-06	8.33e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.82e-06	8.28e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—ovarian cancer	3.75e-06	8.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—ovarian cancer	3.66e-06	7.93e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—ovarian cancer	3.66e-06	7.93e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—ovarian cancer	3.64e-06	7.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—FASN—ovarian cancer	3.6e-06	7.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—YAP1—ovarian cancer	3.6e-06	7.79e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—FASN—ovarian cancer	3.58e-06	7.76e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.56e-06	7.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A5—ovarian cancer	3.54e-06	7.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	3.54e-06	7.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A5—ovarian cancer	3.52e-06	7.63e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—ovarian cancer	3.5e-06	7.59e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—ovarian cancer	3.49e-06	7.56e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAV1—ovarian cancer	3.45e-06	7.47e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—ovarian cancer	3.44e-06	7.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC2A1—ovarian cancer	3.42e-06	7.42e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC2A1—ovarian cancer	3.4e-06	7.37e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—ovarian cancer	3.36e-06	7.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.35e-06	7.26e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.34e-06	7.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.33e-06	7.22e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—ovarian cancer	3.31e-06	7.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1B1—ovarian cancer	3.28e-06	7.11e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1B1—ovarian cancer	3.26e-06	7.07e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—ovarian cancer	3.23e-06	7e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—ovarian cancer	3.19e-06	6.9e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—ovarian cancer	3.14e-06	6.8e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAV1—ovarian cancer	3.13e-06	6.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.13e-06	6.78e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—YAP1—ovarian cancer	3.07e-06	6.66e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—ovarian cancer	3.05e-06	6.61e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.04e-06	6.59e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—ovarian cancer	3.01e-06	6.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—FASN—ovarian cancer	2.93e-06	6.35e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	2.91e-06	6.31e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.9e-06	6.27e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPP2R1A—ovarian cancer	2.89e-06	6.27e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—ovarian cancer	2.88e-06	6.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.88e-06	6.25e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.88e-06	6.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—ovarian cancer	2.86e-06	6.19e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.85e-06	6.18e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—ovarian cancer	2.82e-06	6.11e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—ovarian cancer	2.81e-06	6.1e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.78e-06	6.04e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—ovarian cancer	2.76e-06	5.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.73e-06	5.91e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—ovarian cancer	2.71e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK3—ovarian cancer	2.7e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—ovarian cancer	2.7e-06	5.85e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—ovarian cancer	2.69e-06	5.82e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.67e-06	5.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.67e-06	5.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMS—ovarian cancer	2.65e-06	5.75e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMS—ovarian cancer	2.64e-06	5.72e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK1—ovarian cancer	2.57e-06	5.57e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—ovarian cancer	2.57e-06	5.57e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—ovarian cancer	2.51e-06	5.43e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FASN—ovarian cancer	2.51e-06	5.43e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.46e-06	5.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—ovarian cancer	2.43e-06	5.26e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—ovarian cancer	2.4e-06	5.21e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.38e-06	5.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.37e-06	5.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.36e-06	5.11e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—ovarian cancer	2.36e-06	5.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.33e-06	5.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.28e-06	4.94e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—ovarian cancer	2.23e-06	4.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.2e-06	4.77e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.18e-06	4.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMS—ovarian cancer	2.16e-06	4.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—ovarian cancer	2.16e-06	4.68e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAV1—ovarian cancer	2.14e-06	4.63e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—ovarian cancer	2.13e-06	4.61e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAV1—ovarian cancer	2.13e-06	4.61e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—ovarian cancer	2.1e-06	4.55e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—ovarian cancer	2.08e-06	4.5e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—ovarian cancer	2.06e-06	4.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.04e-06	4.43e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.03e-06	4.4e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.02e-06	4.39e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.01e-06	4.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.95e-06	4.22e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—ovarian cancer	1.94e-06	4.2e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—ovarian cancer	1.89e-06	4.09e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.88e-06	4.07e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMS—ovarian cancer	1.85e-06	4e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—ovarian cancer	1.82e-06	3.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAV1—ovarian cancer	1.74e-06	3.77e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—ovarian cancer	1.74e-06	3.76e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.71e-06	3.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—ovarian cancer	1.7e-06	3.69e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.66e-06	3.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.58e-06	3.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.49e-06	3.23e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAV1—ovarian cancer	1.49e-06	3.22e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—ovarian cancer	1.48e-06	3.22e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—ovarian cancer	1.47e-06	3.18e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.42e-06	3.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.39e-06	3.02e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.35e-06	2.94e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.33e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—ovarian cancer	1.29e-06	2.79e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—ovarian cancer	1.28e-06	2.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.21e-06	2.63e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—ovarian cancer	1.2e-06	2.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.19e-06	2.58e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—ovarian cancer	1.09e-06	2.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—ovarian cancer	1.05e-06	2.27e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.04e-06	2.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—ovarian cancer	9.1e-07	1.97e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—ovarian cancer	9.04e-07	1.96e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—ovarian cancer	8.97e-07	1.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—ovarian cancer	7.43e-07	1.61e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	7.4e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—ovarian cancer	7.39e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—ovarian cancer	6.33e-07	1.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—ovarian cancer	6.05e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—ovarian cancer	5.17e-07	1.12e-05	CbGpPWpGaD
